We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated Microarray Rapid Test Detects SARS-CoV-2 Antibodies in Eight Minutes

By LabMedica International staff writers
Posted on 25 Jun 2021
Print article
Image: Automated Microarray Rapid Test Detects SARS-CoV-2 Antibodies in Eight Minutes (Photo courtesy of S. Kissel / TUM)
Image: Automated Microarray Rapid Test Detects SARS-CoV-2 Antibodies in Eight Minutes (Photo courtesy of S. Kissel / TUM)
Researchers have developed a versatile and reliable automated microarray rapid test for detecting SARS-CoV-2 antibodies that provides results in only eight minutes.

The low-cost automated rapid test developed by an interdisciplinary research team at the Technical University of Munich (Munich, Germany) is highly sensitive and highly specific in detecting the three most important antibodies. IgG antibodies against a protein fragment of the SARS-CoV-2 receptor binding domain (RBD), the spike protein (S1 fragment) and the nucleocapsid protein (N) are simultaneously analyzed.

The measurement is carried out on a foil-based sensor chip using a MCR microarray analysis platform. The device displays its measurement results within a few minutes after injecting a blood sample. Currently, the procedure still takes eight minutes, but building on current research, the waiting time will soon be reduced to just four minutes. New mutant proteins can be very easily integrated into the chip. The microarray technology, which allows to accommodate up to 100 measurement points on a single chip, is so sensitive that it can even determine the concentration of antibodies in a sample. In the long term, the team also plans to include other pathogens in the panel so the assay can be used, for example, to evaluate the effectiveness of an influenza vaccination.

"We have already developed reliable rapid tests for antibiotics in milk and for Legionella using this technology platform," said adjunct teaching professor Dr. Michael Seidel, head of the Bioanalytics and Microanalytical Systems group at TUM's Department of Analytical Chemistry and Water Chemistry. "The system has already proven itself in practical use. Our ‘CoVRapid’ rapid test may thus be deployed in clinics, medical offices and research laboratories in the very near future."

Related Links:
Technical University of Munich

Gold Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Unit-Dose Packaging solution
HLX
New
Automated Nucleic Acid Extractor
eLab
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The FDA clearance for the QIAstat-Dx Respiratory Panel Mini test follows the recent approval of QIAstat-Dx Respiratory Panel Plus (Photo courtesy of QIAGEN)

Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings

Respiratory tract infections are the primary reason for visits to emergency departments and subsequent hospitalizations. In the U.S., it is estimated that there are up to 41 million cases of influenza... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: The new technique allows properties of cancer cells and their surrounding tissue to be analyzed in detail at single-cell level (Photo courtesy of Universität Helsinki/Karolina Punovuori)

New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers

Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more